ecopipam has been researched along with eedq in 1 studies
| Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (eedq) | Trials (eedq) | Recent Studies (post-2010) (eedq) |
|---|---|---|---|---|---|
| 147 | 18 | 34 | 329 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, A; Chipkin, RE; Coffin, VL; Duffy, RA; McQuade, RD | 1 |
1 other study(ies) available for ecopipam and eedq
| Article | Year |
|---|---|
In vivo binding of SCH 39166: a D-1 selective antagonist.
Topics: Animals; Avoidance Learning; Benzazepines; Dopamine Antagonists; Male; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin | 1991 |